Publication July 31, 2026

Abaloparatide Featured in Snyder-Robinson Syndrome Case Report

A new publication referencing abaloparatide appeared on July 31, 2026. The paper, titled "Snyder-Robinson Syndrome Presenting With Severe Osteoporosis and Fragility Fracture: A Case Report and Literature Review," was published in AACE Endocrinology and Diabetes.

The publication is described as a case report combined with a literature review. It addresses a presentation of Snyder-Robinson Syndrome involving severe osteoporosis and fragility fracture.

No additional details about study findings, outcomes, or conclusions were provided in the event data. This brief reports only the existence and basic details of the publication as listed.

Readers interested in abaloparatide, which is an approved compound, can consult the compound overview for further background and context on its regulatory status and general use.

See the full abaloparatide overview

Source: https://pubmed.ncbi.nlm.nih.gov/42978802/